![]() KalVista Pharmaceuticals KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME). | Fractyl Health Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity. | Profil Profil Institut für Stoffwechselforschung is a clinical research organisation for studies related to diabetes and obesity. | |
Founding Date | Founding Date 2011 | Founding Date 2010 | Founding Date 1999 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Porton Down, GB HQ Cambridge, US | Locations Burlington, US HQ | Locations Neuss, DE HQ Mainz, DE |
Employees | Employees 150 | Employees 88 | Employees 200 |
Valuation ($) | Valuation ($) 523.4 m | Valuation ($) 163 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($109.5m) (FY, 2025) | Net income ($141m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 46.2m | Total funding raised $ 190.1m | Total funding raised N/A |
Fractyl Health (formerly known as Fractyl Laboratories) is a metabolic therapeutics company that develops therapies for treating type 2 diabetes (T2D) and obesity.
View companyProfil Institut für Stoffwechselforschung is a clinical research organisation for studies related to diabetes and obesity.
View company